AFM28 specifically induced a significant, concentration-dependent reduction of CD123+ blasts (Fig. 2A–D), resulting in 79% (range 50–100%) and 70% (range 37–86%) lysis of the CD123+ blast population in AML and HR-MDS, respectively. This evidence concerns the gene IL3RA and acute myeloid leukemia.